SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-173869
Filing Date
2023-06-23
Accepted
2023-06-23 16:34:01
Documents
2
Group Members
BAIN CAPITAL LIFE SCIENCES OPPORTUNITIES III, LPBCIP LIFE SCIENCES ASSOCIATES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d492563dsc13ga.htm SC 13G/A 89533
2 EX-99.A d492563dex99a.htm EX-99.A 12239
  Complete submission text file 0001193125-23-173869.txt   103458
Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Life Sciences Fund, L.P. (Filed by) CIK: 0001687968 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Subject) CIK: 0001830487 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92181 | Film No.: 231038230
SIC: 2834 Pharmaceutical Preparations